Matches 151 - 200 out of 296 < 1 2 3 4 5 6 >


Match Document Document Title
6716425 Method of preventing cancer recurrence  
Methods for treating cancer in a mammalian patient having cancer and a functional immune system, and for preventing recurrences of cancer following completion of cancer therapy, are described. The...
6713056 Combined preparation for the treatment of neoplasic diseases or of infectious diseases  
The present invention relates to combined preparation containing as active substance the following individual components, in the form of a kit-of-parts: monocyte derived cells, particularly...
6692958 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations  
Activated lymphocytes derived from cord blood are excellently effective for preventing and treating various types of tumors and various types of infection. With interleukin 2 and/or anti-CD3...
6685936 Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation  
A method of reducing an immune response to a transplant in a recipient by treating said recipient with an amount of suppressor T cells effective to reduce or inhibit host rejection of the...
6682731 Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules  
Complexes of SEQ ID NO: 12 and HLA-A2 can be used to generate CTLs. They can be supplemented with IL-6 and IL-12.
6669965 Method of treating atherosclerosis  
A method of treating or preventing atherosclerosis in a mammalian subject comprises: (a) extracting the aliquot of blood from the subject; (b) treating the aliquot of blood ex vivo with at least...
6663859 Compositions for enhancing the immune response  
D-Ribose and methods for using D-Ribose are provided for enhancing the immune response in mammals. Those with a less than optimal immune response will benefit from oral or parenteral...
6660723 Phosphalohydrins and methods for medicinal administration  
The invention provides compounds comprising at least one phosphohalohydrin group of the formula: where X is a halogen selected from among I, Br, Cl,R1 is selected from among —CH3 and —CH2—CH3,Cat+...
6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens  
A family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as BAGE tumor rejection...
6613320 Defective CD4&plus T-cells that express active CD40-L  
CD4+ cells obtained from individuals with defective CD40L gene and transfected with a vector containing CD40-L are described.
6602510 HLA class I A2 tumor associated antigen peptides and vaccine compositions  
A composition or vaccine composition comprising eight isolated epitopes consisting of YLSGANLNV (SEQ. ID. NO: 1), IMIGVLVGV (SEQ. ID. NO: 2), KLBPVQLWV (SEQ. ID. NO: 3), SMPPPGTRV (SEQ. ID. NO:...
6596275 Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions  
Monocyte derived cells with immunosuppressive properties including an increase in at least one of the following PGE-2, IL-10 and IL-4. Monocyte derived cells with a decreased level of expression...
6589526 Enrichment of dendritic cells from blood  
A method for the enrichment of dendritic cells from the peripheral blood of a mammal is described. Peripheral blood having mononuclear cells from a mammal is provided. The mononuclear cells are...
6576466 Tumoricidal T lymphocytes  
The present invention concerns a mammalian cell line which when co-cultured with lymphocytes during which allogenic stimulation is avoided activates lymphocytes fo form tumoricidal cells, a...
6562334 Canine interleukin 12 administration as an immune disease treatment  
Canine interleukin 12 and a method for producing it by genetic engineering are disclosed. The canine interleukin 12 includes a protein having an amino acid sequence substantially the same as SEQ...
6551589 Method of reducing the chance of attack of cells in a body by the cellular immune systems  
A method of reducing the chance of disease resulting from mononuclear cells in a body attacking desirable cell antigens in the body, such as antigens expressed by normal body cells or desirable...
6544787 Non-myeloablative/lymphoablative conditioning regimen to induce patient anti-donor unresponsiveness in stem cell transplantation  
Serious hematologic malignancies are treated through high dose or lethal chemotherapy and/or radiation therapy conditioning regimens followed by rescue with allogeneic stem cell transplantation...
RE38046 Enhancement of the cellular immune response  
DTH-Effector cells are printed with carbohydrate antigens and used to enhance the cellular immune response. Tumors have been inhibited by DTH-Effector cells primed with epiglycanin and with...
6531453 NKT cell activators containing α-glycosylceramides  
An objective of the present invention is to provide NKT cell-activating agents, therapeutic agents for autoimmune diseases (for example, systemic lupus erythematosus, systemic sclerosis,...
6514493 cDNA clone for tumor rejection antigen gp110 and tumor peptide vaccine  
An isolated cDNA molecule comprising an amino acid sequence encoding an amino-terminal protein fragment of murine glycoprotein 110 is disclosed. Therapeutic methods for treating tumor-bearing...
6497876 Method of stimulating an immune response with activated dendritic cells  
Antigen-expressing, activated dendritic cells are disclosed. Such dendritic cells are used to present tumor, viral or bacterial antigens to T cells, and can be useful in vaccination protocols....
6479286 Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating T cells  
Methods of generating IL-3 expanded populations of monocytes and differentiating the cells into dendritic cells are provided. The methods include use of the dendritic cells to activate T-cells, in...
6455048 Prevention of primary and metastatic neoplastic diseases with hsp70-peptide complexes  
The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases....
6432653 Device and process for cell capture and recovery  
Devices, processes and compositions are provided for effective separation of cells from a mixture of cells, where depletion or positive selection may be employed to provide a cellular population...
6410824 Animal model for psoriasis for the prevention and treatment of psoriasis in humans  
Methods and compositions are provided for the creation and screening of non-human animal models having many of the histologic characteristics of human psoriasis. Immunocompromised host animals are...
6403095 Treatment of primary and metastatic neoplastic diseases with HSP70-peptide complexes  
The present invention relates to methods and compositions for eliciting an immune response and the prevention-and treatment of primary and metastatic neoplastic diseases and infectious diseases....
6403080 Methods of modulating an immune response to antigen, and cells for use in the method  
Disclosed are methods and compositions wherein opsonin-enhanced cells, that is, cells which have been 1) modified so as to express an opsonin from a recombinant nucleic acid, 2) modified so as to...
6399070 Methods and compositions for eliciting an immune response with hsp90-peptide complexes  
The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases....
6399069 Prevention of infectious diseases with hsp70-peptide complexes  
The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases....
6391306 Treatment of infectious diseases with hsp90-peptide complexes  
The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases....
6383491 Prevention of infectious diseases with hsp90-peptide complexes  
The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases....
6383492 Treatment of infectious diseases with gp96-peptide complexes  
The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases....
6383481 Method for transplantation of hemopoietic stem cells  
This invention relates to a method of transplanting hemopoietic stem cells which Comprises subjecting a recipient to a radiation treatment using an effective exposure dose for hemopoietic stem...
6383494 Methods and composition for eliciting an immune response with gp96-peptide complexes  
The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases....
6379672 Prevention of infectious diseases with gp96-peptide complexes  
The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases....
6375950 Methods for inducing T cell unresponsiveness to donor tissue or organ in a recipient with gp39 antagonists  
Methods for inducing T cell tolerance to a tissue or organ graft in a transplant recipeint are disclosed. The methods involve administering to a subject: 1) an allogeneic or xenogeneic cell which...
6375953 Treatment of infectious diseases with HSP70-peptide complexes  
The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases....
6368593 Enhanced immunogenic cell populations prepared using H2 receptor antagonists  
This invention provides a method to enhance alloactivation in a mixed lymphocyte culture. Alloactivated cells are effective in treating tumors when implanted into a tumor site or coinjected with...
6358506 Use of cytokines and mitogens to inhibit pathological immune responses  
The invention is generally related to methods of treating autoimmune diseases, including both antibody-mediated and cell-mediated disorders.
6352694 Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells  
Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds...
6322790 Compositions and methods for eliciting an immune response using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy  
The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic noeplastic diseases and infectious diseases....
6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells  
A method of treating graft-vs-host diseases by administration of bone marrow and an anti-gp39 antibody specific to human gp39 is provided.
6294167 Pharmaceutical compositions for immunotherapy containing antibodies which specifically recognize the MHCII antigen of a patient to be treated  
The invention concerns medicaments containing antibodies which have at least one specificity and detect the MHCII antigen of a patient to be treated. The invention further concerns antibodies with...
6267955 Mononuclear phagocytes and their use to promote axonal regeneration  
Methods and compositions are disclosed for the use of allogeneic mononuclear phagocytes to promote axonal regeneration in the central nervous system of a mammal. In one embodiment, allogeneic...
6261839 Method for the induction of a NK cell-mediated immune response  
According to the present invention, there is provided a method for the induction of a NK cell-mediated immune response ex vivo characterized in that a physiological cell suspension containing at...
6258357 Inhibition of graft versus host disease  
The development of graft versus host disease in a mammalian patient undergoing cell transplantation therapy for treatment of a bone marrow mediated disease, is prevented or alleviated by...
6251385 Method of cancer treatment  
Treatment of solid tumors, including their metastases, without radiation, surgery or standard chemotherapeutic agents is described. Ex vivo stimulation of cells, selection of specific Vβ subsets...
6224859 Composition containing immature mammalian dendritic cells for enhancing tolerogenicity to foreign graft  
A novel transplantation method for enhancing tolerogenicity in a host mammal to a transplant graft specimen from a donor mammal is disclosed. According to this method, immature mammalian dendritic...
6203787 Treating tumors using implants comprising combinations of allogeneic cells  
This invention provides methods and compositions for treating tumors by implanting near the tumor an alloactivated cell population. The cell population is made up of a plurality of third-party...
6200606 Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration  
The present invention relates to the isolation of cartilage or bone precursor cells from hematopoietic and non-hematopoietic cells and their use in bone and cartilage regeneration procedures. The...

Matches 151 - 200 out of 296 < 1 2 3 4 5 6 >